Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
| ▸ | KCNA4 | P22459 | 1/20 | 0.34 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.34 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18119744 | 0.89 | SMN1; SMN2 (0.62) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL10932117 | 0.83 | MEN1 (0.63) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL18119746 | 0.83 | SMN1; SMN2 (0.57) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL11460056 | 0.82 | SMN1; SMN2 (0.56) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL1179726 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL19923127 | 0.80 | SMN1; SMN2 (0.58) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL4261995 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL9946118 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL8608558 | 0.79 | MEN1 (0.69) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL22160318 | 0.78 | SMN1; SMN2 (0.53) | SMN1; SMN2NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108941-A | Preparation method and application of covalent organic framework nano material for pyroelectric power therapy | 华东理工大学 | 2024-05-31 | — | — | CN | claimed |
| EP-0280975-A1 | Processes for the production of substituted benzaldehydes, and intermediate products obtained by these processes | F. HOFFMANN-LA ROCHE AG (CH) | 1988-09-07 | — | — | EP | claimed |
| CN-118108941-A | Preparation method and application of covalent organic framework nano material for pyroelectric power therapy | 华东理工大学 | 2024-05-31 | — | — | CN | disclosed |
| US-8629269-B2 | Dye for a dye-sensitised solar cell, and a solar cell comprising the same | SOLARSYS CO., LTD. (KR) | 2014-01-14 | — | — | US | disclosed |
| US-8629269-B2 | Dye for a dye-sensitised solar cell, and a solar cell comprising the same | SOLARSYS CO., LTD. (KR) | 2014-01-14 | — | — | US | disclosed |
| US-20110028716-A1 | Dye for a Dye-Sensitised Solar Cell, and a Solar Cell Comprising the Same | SOLARSYS CO., LTD. (KR) | 2011-02-03 | — | — | US | disclosed |
| US-20110028716-A1 | Dye for a Dye-Sensitised Solar Cell, and a Solar Cell Comprising the Same | SOLARSYS CO., LTD. (KR) | 2011-02-03 | — | — | US | disclosed |
| EP-0280975-B1 | PROCESSES FOR THE PRODUCTION OF SUBSTITUTED BENZALDEHYDES, AND INTERMEDIATE PRODUCTS OBTAINED BY THESE PROCESSES | F. HOFFMANN-LA ROCHE AG (CH) | 1992-07-08 | — | — | EP | disclosed |
| EP-0280975-A1 | Processes for the production of substituted benzaldehydes, and intermediate products obtained by these processes | F. HOFFMANN-LA ROCHE AG (CH) | 1988-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028716-A1 | Dye for a Dye-Sensitised Solar Cell, and a Solar Cell Comprising the Same | DSG1, CRY1, DHODH | SMN1; SMN2 4742/4885NPC1 3035/4885RAB9A 1222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.